Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Neoplasms, Primary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Not applicableUnknownNCT05660499
What this trial is testing

Impact of the Development of Pediatric Palliative Care

Who this might be right for
Primary Brain Tumor
University Hospital, Strasbourg, France 40
Large-scale testing (Phase 3)WithdrawnNCT00003564
What this trial is testing

Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT07698899
What this trial is testing

177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

Who this might be right for
Recurrent MedulloblastomaRefractory MedulloblastomaCNS Metastases+1 more
Memorial Sloan Kettering Cancer Center 18
Not applicableEnrolling By InvitationNCT06583395
What this trial is testing

Quest to Analyze One Thousand Humans Meditating

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Angina, StableAnxiety+52 more
Tobias Moeller-Bertram 3,000
Early research (Phase 1)Study completedNCT02323880
What this trial is testing

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Who this might be right for
Malignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more
Children's Oncology Group 59
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableEnded earlyNCT01251913
What this trial is testing

A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes

Who this might be right for
EpendymomasGliomasPNET+2 more
National Cancer Institute (NCI) 7
Not applicableStudy completedNCT02599142
What this trial is testing

Comparing Immobilisation Shells in Cranial Radiotherapy

Who this might be right for
Brain MetastasesBone MetastasesBrain Tumor, Primary+2 more
Royal Marsden NHS Foundation Trust 41
Testing effectiveness (Phase 2)Study completedNCT06322342
What this trial is testing

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Who this might be right for
Central Nervous System (CNS) LesionsBrain MetastasesBrain Neoplasms+22 more
Reveal Pharmaceuticals Inc. 18
Not applicableLooking for participantsNCT07476781
What this trial is testing

Exploring the Feasibility of Cerebrospinal Fluid (CSF) and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and Primary Central Nervous System (CNS) Tumours: A Pilot Study

Who this might be right for
Solid Tumor MalignanciesBrain MetastasasesLeptomeningeal Disease (LMD)+1 more
Sunnybrook Health Sciences Centre 60
Testing effectiveness (Phase 2)Study completedNCT00003465
What this trial is testing

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 60
Testing effectiveness (Phase 2)Study completedNCT00003475
What this trial is testing

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

Who this might be right for
Malignant Brain Tumors
Burzynski Research Institute 40